Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia ; volume:23 ; number:1 ; day:24 ; month:1 ; year:2023 ; pages:1-13 ; date:12.2023
BMC psychiatry ; 23, Heft 1 (24.1.2023), 1-13, 12.2023
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12888-023-04552-y
- URN
-
urn:nbn:de:101:1-2023033122101018005759
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Haddad, Chadia
- Salameh, Pascale
- Sacre, Hala
- Clément, Jean-Pierre
- Calvet, Benjamin
- SpringerLink (Online service)
Other Objects (12)
Predictors of switching antipsychotic medications in the treatment of schizophrenia
The interplay between vitamin D, exposure of anticholinergic antipsychotics and cognition in schizophrenia
The effects of anticholinergic medications on cognition in children: a systematic review and meta-analysis
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
Antipsychotic-induced prolactin elevation in premenopausal women with schizophrenia: associations with estrogen, disease severity and cognition
Comparative meta-analysis of the neurotransmitter alterations by antipsychotic medications
Exploring the interplay of psychiatric symptoms, antipsychotic medications, side effects, employment status, and quality of life in Chronic Schizophrenia
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Gender differences in the use of atypical antipsychotic medications for ICU delirium
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Predictors of switching antipsychotic medications in the treatment of schizophrenia
The interplay between vitamin D, exposure of anticholinergic antipsychotics and cognition in schizophrenia
The effects of anticholinergic medications on cognition in children: a systematic review and meta-analysis
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
Antipsychotic-induced prolactin elevation in premenopausal women with schizophrenia: associations with estrogen, disease severity and cognition
Comparative meta-analysis of the neurotransmitter alterations by antipsychotic medications
Exploring the interplay of psychiatric symptoms, antipsychotic medications, side effects, employment status, and quality of life in Chronic Schizophrenia
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Gender differences in the use of atypical antipsychotic medications for ICU delirium
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Predictors of switching antipsychotic medications in the treatment of schizophrenia
The interplay between vitamin D, exposure of anticholinergic antipsychotics and cognition in schizophrenia
The effects of anticholinergic medications on cognition in children: a systematic review and meta-analysis
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
Antipsychotic-induced prolactin elevation in premenopausal women with schizophrenia: associations with estrogen, disease severity and cognition
Comparative meta-analysis of the neurotransmitter alterations by antipsychotic medications
Exploring the interplay of psychiatric symptoms, antipsychotic medications, side effects, employment status, and quality of life in Chronic Schizophrenia
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Gender differences in the use of atypical antipsychotic medications for ICU delirium
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia